• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [21797 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2016     Andalusian Health Technology Assessment Area (AETSA) Safety and effectiveness of perfusion machine in solid organ transplantation
2011     Penn Medicine Center for Evidence-based Practice (CEP) Safety and effectiveness of rhBMP-2 (infuse bone graft) for spinal fusion: 2011 update
2003     Institute for Clinical Effectiveness and Health Policy (IECS) Safety and efficacy of cochlear implants
2007     Institute of Health Economics (IHE) Safety and efficacy of inhaled nitric oxide in the management of hypoxemic respiratory failure in adults with acute respiratory distress syndrome
2002     Centre for Clinical Effectiveness (CCE) Safety and efficacy of percutaneous vertebroplasty in symptomatic osteoporotic vertebral compression fractures
2007     Quality Improvement Scotland (NHS QIS ) Safety and risk associated with free standing midwife led maternity units (MLMU)
2012     Scottish Health Technologies Group (SHTG) Safety and risk associated with free standing midwife led maternity units. This evidence note updates evidence note 18 published in August 2007
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Safety of air vents in psychiatric units in a hospital setting: a review of the clinical evidence and guidelines
1999     Health Council of the Netherlands Gezondheidsraad (GR) Safety of amino acid supplementation
2022     NIHR Health Services and Delivery Research programme Safety of disinvestment in mid- to late-term follow-up post primary hip and knee replacement: the UK SAFE evidence synthesis and recommendations
1992     Health Council of the Netherlands Gezondheidsraad (GR) Safety of food produced by new biotechnology
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Safety of leflunomide and methotrexate as combination therapy for rheumatoid arthritis: a review of the clinical evidence
2011     Agency for Healthcare Research and Quality (AHRQ) Safety of probiotics used to reduce risk and prevent or treat disease
2014     Penn Medicine Center for Evidence-based Practice (CEP) Safety of renal biopsy for patients taking aspirin
2014     Agency for Healthcare Research and Quality (AHRQ) Safety of vaccines used for routine immunization in the United States
2021     Agency for Healthcare Research and Quality (AHRQ) Safety of vaccines used for routine immunization in the United States: an update
2020     Norwegian Institute of Public Health (NIPH) Safety, clinical effectiveness, predictive accuracy and cost effectiveness of blood based tests for women with suspected preeclampsia: a health technology assessment
2003     Andalusian Health Technology Assessment Area (AETSA) Safety, efficacy and efficiency of transmyocardial laser. Update of evidence-Systematic Review.
2011     NIHR Horizon Scanning Centre (NIHR HSC) Safinamide for early stage parkinson's disease - adjuvant therapy
2011     NIHR Horizon Scanning Centre (NIHR HSC) Safinamide for mid-to-late stage parkinson's disease - adjuvant therapy
2015     NIHR Health Technology Assessment programme Saline in Acute Bronchiolitis RCT and Economic evaluation: hypertonic saline in acute bronchiolitis - randomised controlled trial and systematic review
1999     Medical Services Advisory Committee (MSAC) Saline infusion sonohysterography
2005     HAYES, Inc. Salivary estriol test for preterm labor
2013     HAYES, Inc. Salivary hormone testing for menopausal women
2000     Health Council of the Netherlands Gezondheidsraad (GR) Salt intake and hypertension
1999     Medical Services Advisory Committee (MSAC) Samarium-153-lexidronam for bone pain due to skeletal metastases
2022     WorkSafeBC SANUWAVE therapy for wound healing
2016     NIHR Horizon Scanning Centre (NIHR HSC) Sapacitabine - acute myeloid leukaemia: patients ≥70 years of age; not candidates for standard intensive therapy – first line
2006     NIHR Horizon Scanning Centre (NIHR HSC) Sapropterin dihydrochloride for phenylketonuria: horizon scanning technology briefing
2012     NIHR Horizon Scanning Centre (NIHR HSC) SAR-302503 for myelofibrosis – first line
2012     NIHR Horizon Scanning Centre (NIHR HSC) SAR236553/REGN727 for the reduction of elevated total cholesterol and low density lipoprotein cholesterol
2008     NIHR Horizon Scanning Centre (NIHR HSC) Saredutant (SR-48968) for depression and anxiety
2015     NIHR Horizon Scanning Centre (NIHR HSC) Sarilumab for moderate to severe active rheumatoid arthritis
2021     European Network for Health Technology Assessment (EUnetHTA) Sarilumab for the treatment of COVID-19
2022     WorkSafeBC Satir brief transformational therapy as treatment for trauma-related disorders including PTSD
2005     NIHR Health Technology Assessment programme Satisfaction in Life for Children With Own Report Measures (SILCWORM)
2009     NIHR Horizon Scanning Centre (NIHR HSC) Sativex for adults experiencing pain from cancer
2009     NIHR Horizon Scanning Centre (NIHR HSC) Sativex for spasticity in multiple sclerosis
2005     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Sativex for the management of multiple sclerosis symptoms
2006     NIHR Horizon Scanning Centre (NIHR HSC) Satraplatin for second-line hormone-refractory prostate cancer: horizon scanning technology briefing
2004     NIHR Horizon Scanning Centre (NIHR HSC) Satraplatin for second-line treatment of hormone-refractory prostate cancer - horizon scanning review
2009     HAYES, Inc. Saw palmetto for benign prostatic hyperplasia
2008     NIHR Horizon Scanning Centre (NIHR HSC) Saxagliptin (BMS 477118) for type 2 diabetes
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Saxagliptin (Onglyza - Bristol-Myers Squibb/AstraZeneca Canada Inc.) indication: type 2 diabetes mellitus
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Saxagliptin (Onglyza®)
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Saxagliptin (Onglyza®)
2013     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Saxagliptin (Onglyza®)
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Saxagliptin + metformin (Komboglyze — AstraZeneca) indication: type 2 diabetes mellitus
2008     Adelaide Health Technology Assessment (AHTA) Scalable Medical Alert Response Technology (SMART) for monitoring emergency department patients
2000     West Midlands Health Technology Assessment Collaboration (WMHTAC) Scale and polish for chronic periodontal disease
2013     Penn Medicine Center for Evidence-based Practice (CEP) Scales for assessing inpatients' risk of accidental falls
2018     Penn Medicine Center for Evidence-based Practice (CEP) Scales for Assessing Patients Receiving Moderate Sedation
2005     The Swedish Council on Health Technology Assessment (SBU) Scalp cooling to prevent chemotherapy-induced hair loss - early assessment briefs (Alert)
2007     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Scalpel safety in the operative setting: a systematic review
1996     Alberta Heritage Foundation for Medical Research (AHFMR) Scanning laser ophthalmoscope for diagnosis and monitoring of glaucoma
2002     HAYES, Inc. Scanning laser polarimetry for detection and monitoring of glaucoma
2008     HAYES, Inc. Scanning laser polarimetry for detection and monitoring of glaucoma
2022     Agency for Healthcare Research and Quality (AHRQ) Schedule of visits and televisits for routine antenatal care
1993     Danish Institute for Health Services Research (DSI) Schizophrenia, Consensus statement
2002     National Institute for Clinical Excellence (NICE) Schizophrenia: core interventions in the treatment and management of schizophrenia in primary and secondary care
2021     NIHR Public Health Research (PHR) programme School-based interventions to prevent anxiety, depression and conduct disorder in children and young people: a systematic review and network meta-analysis
2010     National Institute for Health and Care Excellence (NICE) School-based interventions to prevent the uptake of smoking among children
2010     NIHR Health Technology Assessment programme School-linked sexual health services for young people (SSHYP): a survey and systematic review concerning current models, effectiveness, cost-effectiveness and research opportunities
1998     Australian Health Technology Advisory Committee (AHTAC) Scientific literature review of lung transplantation
2010     Adelaide Health Technology Assessment (AHTA) Scintimammograms or breast-specific gamma imaging (BSGI) for the evaluation of disease spread in women diagnosed with breast cancer
2003     Medical Advisory Secretariat (MAS) Scintimammography
2007     Medical Advisory Secretariat (MAS) Scintimammography as an adjunctive breast imaging technology: an evidence-based analysis
2004     National Institute for Clinical Excellence (NICE) Scleral expansion surgery for presbyopia
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Scleral support surgery for pathologic myopia
2005     HAYES, Inc. Sclerotherapy for esophageal varices
2004     Alberta Heritage Foundation for Medical Research (AHFMR) Sclerotherapy for leg varicose veins
2000     HAYES, Inc. Sclerotherapy for symptomatic varicose veins
2004     HAYES, Inc. Sclerotherapy for symptomatic varicose veins
2003     Alberta Heritage Foundation for Medical Research (AHFMR) Sclerotherapy for varicose veins of the legs
2000     HAYES, Inc. Sclerotherapy, joint and ligamentous injections
2000     HAYES, Inc. Sclerotherapy, oesophageal varices
2004     Adelaide Health Technology Assessment (AHTA) ScopeGuide (TM): magnetic endoscopic imaging of the colon for patients requiring colonoscopy
1999     University of York Scoping review of literature on the health and care of mentally disordered offenders
2004     University of York Scoping review of sabotage and/or tampering in the NHS
2001     University of York Scoping review of the effectiveness of mental health services
2003     NIHR Health Technology Assessment programme Scoping study on the assessment of the star ratings
2002     Centre for Clinical Effectiveness (CCE) Scoring systems for assessing postoperative risk in colorectal surgery
2005     NIHR Health Technology Assessment programme Scottish trial of arthroplasty or reduction for subcapital fractures (STARS)- primary research
2012     NIHR Horizon Scanning Centre (NIHR HSC) SCOUT DS® and Diab-spot for type 2 diabetes screening
2016     HAYES, Inc. Scrambler/Calmare Pain Therapy (Calmare Therapeutics Inc.) for the management of chronic pain related to cancer or cancer treatment
2016     HAYES, Inc. Scrambler/Calmare Pain Therapy (Calmare Therapeutics Inc.) for the management of pain not related to cancer
2008     Health Council of the Netherlands Gezondheidsraad (GR) Screening : between hope and hype
2010     Agency for Healthcare Research and Quality (AHRQ) Screening adults for bladder cancer: update of the 2004 evidence review for the U.S. Preventive Services Task Force
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening and assessment tools for patients with chronic disease in therapeutic exercise program: a review of the clinical evidence and guidelines
2012     Agency for Healthcare Research and Quality (AHRQ) Screening and diagnosing gestational diabetes mellitus
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening and diagnostic tools for autism spectrum disorder in children: a review of guidelines
2005     Agency for Healthcare Research and Quality (AHRQ) Screening and interventions for childhood overweight: evidence synthesis
2003     Agency for Healthcare Research and Quality (AHRQ) Screening and interventions for overweight and obesity in adults
2013     Health Quality Ontario (HQO) Screening and management of depression for adults with chronic diseases: an evidence-based analysis
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Screening and prevention programmes for children and adolescents from 6 to 14 years. Results from selected countries and recommendations from evidence-based guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening and risk stratification for diabetic foot ulcers: a review of clinical effectiveness, cost-effectiveness, and guidelines
2020     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Screening and testing for COVID-19 before surgery
2008     Agency for Healthcare Research and Quality (AHRQ) Screening and treatment for bacterial vaginosis in pregnancy: systematic review to update the 2001 U.S. Preventive Services Task Force recommendation
1999     Health Council of the Netherlands Gezondheidsraad (GR) Screening and treatment of adolescents with schizophrenia
2005     Adelaide Health Technology Assessment (AHTA) Screening and treatment of gestational diabetes mellitus